id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FTC-2012-0061-0001,FTC,FTC-2012-0061,Proposed Consent Agreements: Novartis,Notice,,2012-07-20T04:00:00Z,2012,7,2012-07-20T04:00:00Z,2012-08-17T03:59:59Z,2012-07-24T19:15:18Z,2012-17660,0,0,09000064810a6fd4